The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	9.59B
Revenue (ttm)	12.84B
Net Income (ttm)	769.78M
Shares Out	31.24M
EPS (ttm)	24.64
PE Ratio	12.45
Forward PE	n/a
Dividend	6.40 (2.09%)
Ex-Dividend Date	Oct 27, 2025

Volume	10,191
Average Volume	38,683
Open	305.30
Previous Close	308.60
Day's Range	305.30 - 310.80
52-Week Range	270.30 - 334.80
Beta	0.14
RSI	52.56
Earnings Date	Nov 11, 2025

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 5,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2025, DSE:IBNSINA's revenue was 11.88 billion, an increase of 4.51% compared to the previous year's 11.37 billion. Earnings were 633.19 million, a decrease of -5.57%.